ClinicalTrials HQ

Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma

Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma

Active, not recruiting · NCT02544308 · Registry updated 2022-12-23
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Trial of Immunomodulatory Therapy in High Risk Solitary Bone PlasmacytomaNeoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, neoplasm, plasma cell neoplasm, plasmacytomaActive, not recruitingPhase 32022-12-23NCT02544308

3 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Cancer Research UK59
Celgene53
University College, London222

13 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Beatson West of Scotland Cancer CentreGlasgowUnited Kingdom18
Blackpool Victoria HospitalBlackpoolUnited Kingdom7
Freeman HospitalNewcastleUnited Kingdom14
Mount Vernon Cancer CentreNorthwoodUnited Kingdom5
Royal Preston HospitalPrestonUnited Kingdom3
Royal United HospitalBathUnited Kingdom6
Salisbury District HospitalSalisburyUnited Kingdom3
Southampton General HospitalSouthamptonUnited Kingdom24
St James University hospitalLeedsUnited Kingdom4
The Christie HospitalManchesterUnited Kingdom13
University College London HospitalLondonUnited Kingdom32
University Hospital WalesCardiffUnited Kingdom2
Velindre Cancer CentreCardiffUnited Kingdom12